We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Keeps Teva on the Hook to GSK for $236 Million in Patent Dispute
Appeals Court Keeps Teva on the Hook to GSK for $236 Million in Patent Dispute
The U.S. Court of Appeals for the Federal Circuit has affirmed an earlier judgment that Teva Pharmaceuticals has to pay $235.5 million in damages to GlaxoSmithKline (GSK) for patent infringement.